ADDIFAB APS

Their core work

AddiFab is a Danish manufacturing technology SME that has developed a proprietary process called Sacrificial Thermoplastic Injection Moulding (STIM), which combines 3D-printed sacrificial molds with conventional injection molding to produce small, geometrically complex metal components. Their technology addresses a long-standing gap in manufacturing: producing intricate metal parts in low-to-medium volumes where traditional tooling is too expensive and standard additive manufacturing lacks the material properties required. By using a thermoplastic scaffold that is later removed, they enable shapes that would otherwise be impossible or uneconomical with standard metal injection molding (MIM) or CNC machining. Their core value proposition is cost-effective, design-unconstrained metal part production for industries that need precision in small series.

What they specialise in

How they've shifted over time

AddiFab's entire H2020 history is a single technology development arc: Phase 1 feasibility study in 2017–2018, followed immediately by Phase 2 commercialization in 2019–2020. There is no meaningful thematic shift — both projects carry the identical STIM-MC acronym and title, indicating sustained, focused development of one core technology rather than a broadening of scope. The evolution is one of maturity rather than direction: from proving the concept to scaling and bringing it to market.

AddiFab is on a single-track commercialization path for their STIM technology; a future collaborator would most likely find them seeking distribution partnerships, application-specific pilots, or supply chain integration rather than further basic research.

How they like to work

AddiFab operates exclusively as a solo coordinator — both projects were run as single-beneficiary SME Instrument grants with no consortium partners. This is entirely consistent with the SME Instrument funding model, which is designed for individual companies developing proprietary technology. It tells us nothing about their willingness to collaborate, but it does mean they have no established consortium network through H2020 and would be entering any multi-partner project as a relative newcomer to that dynamic.

AddiFab has no recorded consortium partners across their two H2020 projects, which is characteristic of SME Instrument funding rather than an indicator of isolation. Their collaboration footprint within the European research system is effectively zero at the formal project level.

What sets them apart

AddiFab occupies a narrow but defensible niche: they are not a general additive manufacturing company, and they are not a standard metal injection molder — they sit at the intersection of both, offering a route to complex metal geometries that neither camp can easily replicate. For a consortium builder, they bring a proprietary manufacturing process that could serve as the production backbone for projects needing novel small metal components, particularly in medical devices, aerospace, or precision instrumentation where design freedom and small-batch economics both matter.

Highlights from their portfolio

• STIM-MC (Phase 2)
  The largest of the two projects at €1,608,801 represents the full commercial development push for their core technology, funded under the highly competitive SME Instrument Phase 2 — a grant awarded to fewer than 5% of applicants.
• STIM-MC (Phase 1)
  The Phase 1 feasibility award (€50,000) validated the STIM concept sufficiently to secure Phase 2 funding, demonstrating a clean technology readiness progression within a two-year window.